The Houston Chronicle analyzed the most recent salary data from Texas' lone independent university and its seven university ...

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Matt Kampmeier of Plymouth was diagnosed with Stage 4 glioblastoma and lost some of his vision -- but still plays pickleball ...

Giving patients more direct control over their healthcare data is a frequent talking point among healthcare leaders. | The ...

On Feb. 19, the University of Texas MD Anderson Cancer Center and Texas Children’s Hospital, both based in Houston, launched a joint venture with one mission: to end childhood cancer.

Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) designed to ...

Platform aims to simplify and improve patient consent process to strengthen future initiativesHOUSTON and SAN FRANCISCO, June 09, 2025 (GLO ...

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

You may have heard that moderate intensity exercise — even brisk walking — may be linked to a 37 percent reduction in risk of ...

The Best of ASCO UAE Conference 2025, organised by SEHA, part of PureHealth Group, in collaboration with Tawam Hospital, ...

Quest Diagnostics to develop MCaST blood test based on MD Anderson Technology: Secaucus, New Jersey Wednesday, June 11, 2025, 13:00 Hrs [IST] Quest Diagnostics, a leading provider ...